GB0510469D0 - Insulin sensitization to slow down pubertal tempo and to augment pubertal growth - Google Patents
Insulin sensitization to slow down pubertal tempo and to augment pubertal growthInfo
- Publication number
- GB0510469D0 GB0510469D0 GBGB0510469.0A GB0510469A GB0510469D0 GB 0510469 D0 GB0510469 D0 GB 0510469D0 GB 0510469 A GB0510469 A GB 0510469A GB 0510469 D0 GB0510469 D0 GB 0510469D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pubertal
- tempo
- augment
- slow down
- growth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
- 230000002294 pubertal effect Effects 0.000 title 2
- 102000004877 Insulin Human genes 0.000 title 1
- 108090001061 Insulin Proteins 0.000 title 1
- 206010070834 Sensitisation Diseases 0.000 title 1
- 229940125396 insulin Drugs 0.000 title 1
- 230000008313 sensitization Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0510469.0A GB0510469D0 (en) | 2005-05-23 | 2005-05-23 | Insulin sensitization to slow down pubertal tempo and to augment pubertal growth |
| PCT/BE2006/000060 WO2006125285A1 (en) | 2005-05-23 | 2006-05-23 | Insulin sensitization to slow down pubertal tempo and to augment pubertal growth |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0510469.0A GB0510469D0 (en) | 2005-05-23 | 2005-05-23 | Insulin sensitization to slow down pubertal tempo and to augment pubertal growth |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0510469D0 true GB0510469D0 (en) | 2005-06-29 |
Family
ID=34834482
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0510469.0A Ceased GB0510469D0 (en) | 2005-05-23 | 2005-05-23 | Insulin sensitization to slow down pubertal tempo and to augment pubertal growth |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB0510469D0 (en) |
| WO (1) | WO2006125285A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2462720C1 (en) * | 2011-10-10 | 2012-09-27 | Нина Викторовна Болотова | Method for describing nature of arrested sexual development in boys in puberty with growth retardation |
| LT3548026T (en) | 2016-12-01 | 2021-05-25 | Minoryx Therapeutics S.L. | 5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione for treating nonalcoholic fatty liver disease |
| KR20210031867A (en) * | 2018-06-06 | 2021-03-23 | 미노릭스 테라퓨틱스 에스.엘. | Use of 5-[[4-[2-[5-acetylpyridin-2-yl]ethoxy]benzyl]-1,3-thiazolidine-2,4-dione and salts thereof |
-
2005
- 2005-05-23 GB GBGB0510469.0A patent/GB0510469D0/en not_active Ceased
-
2006
- 2006-05-23 WO PCT/BE2006/000060 patent/WO2006125285A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006125285A1 (en) | 2006-11-30 |
| WO2006125285B1 (en) | 2007-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2424499B (en) | Processor with variable wake-up and sleep latency and method for managing power therein | |
| GB2422212B (en) | Portable timepiece | |
| IL212977A0 (en) | Micrornas and uses thereof | |
| EP1708557A4 (en) | Compensed growing medium | |
| EP1725498A4 (en) | Synthesis of zsm-48 crystals with heterostructural, non zsm-48, seeding | |
| ZA200710173B (en) | Tygecycline and methods of preparing 9-nitrominocycline | |
| IL176923A0 (en) | Structured materials and methods | |
| GB2412889B (en) | Biomass material | |
| PL381358A1 (en) | Methods and indirec compounds | |
| EP1884031A4 (en) | Pll with phase clipping and resynchronization | |
| EP1960992A4 (en) | Music string and instrument comprising said string | |
| EP1735281A4 (en) | Synthesis of indenoisoquinoliniums and methods of use | |
| ZA200704758B (en) | Molar implant and method | |
| GB2422213B (en) | Portable timepiece | |
| EP1940295A4 (en) | Resonant nanostructures and methods of use | |
| IL183136A0 (en) | Modified alginates, methods of production and use | |
| GB0510469D0 (en) | Insulin sensitization to slow down pubertal tempo and to augment pubertal growth | |
| HK1083324A1 (en) | Biomass material | |
| GB0406835D0 (en) | Improvements in and relating to implants | |
| EP1802560A4 (en) | Halocombstatins and methods of synthesis thereof | |
| ZA200903645B (en) | Stable S-nitrosothiols, method of synthesis and use | |
| HK1099931A1 (en) | Synthesising method and benzoxathiepine intermediates | |
| GB0505620D0 (en) | Methods and materials therefor | |
| AU158223S (en) | Wristwatch | |
| ES1059705Y (en) | NATURAL MOTHER MASS FERMENTER. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |